Abstract:

Hepatitis B virus is recognized as important occupational risk to health care personnel. This descriptive cross-sectional study was conducted among health care personnel (HCP) in different health care facilities in Osogbo, Osun State, Nigeria to determine coverage of HBV vaccination and determine if coverage and taking of post exposure treatment was dependent on category of work place. Mean knowledge of transmission, vaccination schedules and post exposure management was good (55.8%), HCP working at teaching hospital tend to have better knowledge followed by those in primary health centre than those working in general and private hospitals. About half of the HCP (48.7%) who participated in this study felt they were at risk of exposure to HBV by virtue of their job description. Workers in primary care centers followed by those in teaching hospitals are likely to receive booster HB vaccine following exposure than workers in other health facility setting.

Keywords: Hepatitis B virus, Vaccination, Immunization, Post-exposure

References:

[1]. Alberti A, Caporaso N (January 2011). "HBV therapy: guidelines and open issues". Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 43 (Suppl 1): S57–63.

[2]. Aspinall EJ, Hawkins G, Fraser A, Hutchinson SJ, Goldberg D (December 2011). "Hepatitis B prevention, diagnosis, treatment and care: a review". Occupational medicine (Oxford, England) 61(8): 531–40.

[3]. Bell SJ, Nguyen T (2009). "The management of hepatitis B" (PDF). Aust Prescr 23 (4): 99–104.

[4]. Bonino F, Chiaberge E, Maran E, Piantino P (1987). "Serological markers of HBV infectivity". Ann. Ist. Super. Sanita 24 (2): 217– 23.

[5]. Buddeberg F, Schimmer BB, Spahn DR (September 2008). "Transfusion-transmissible infections and transfusion-related immunomodulation". Best Practice & Research. Clinical Anaesthesiology 22 (3): 503–17.

[6]. Chang MH (June 2007). "Hepatitis B virus infection". Semin Fetal Neonatal Med 12 (3): 160– 167.

[7]. Centers for Disease Control and Prevention. General recommendations on immunizations of the advisory committee on immunization practices. (ACIP). MMWR morb Mortal wkly Rep. 2006;55(pp-15):32-33.

[8]. Dienstag JL (2008). "Hepatitis B Virus Infection". New England Journal of Medicine 359 (14): 1486–1500.

[9]. Emma Bourke (14 June 2013). "Preventive drug could reduce HIV transmission among injecting drug users". The Conversation Australia. The Conversation Media Group. Retrieved 17 June 2013.

[10]. Habiba S.A, Alrashidi G.A, Al-otaibi A.E.M. Knowledge, attitude and behavior of health care workers regarding hepatitis B infection in primary health care, Kuwait. Greener Journal of Medical Sciences. Vol. 2 (4), pp. 077-083, August 2012.

[11]. "Hepatitis B FAQs for the Public". Centers for Disease Control and Prevention. Retrieved 2015- 08-24.

[12]. Fairley CK, Read TR (February 2012). "Vaccination against sexually transmitted infections". Current Opinion in Infectious Diseases 25 (1): 66–72.

[13]. Fatusi AO, Fatusi OA, Esimai AO, et al. Acceptance of hepatitis B vaccine by workers in a Nigerian teaching hospital. East Afr Med J 2000; 77:608-12.

[14]. Guidelines for the prevention, care and treatment of persons with chronic hepatitis b infection (PDF). World Health Organization. Mar 2015.

[15]. Hollinger FB, Lau DT (December 2006). "Hepatitis B: the pathway to recovery through treatment". Gastroenterology Clinics of North America 35 (4): 895–931.

[16]. "Hepatitis B FAQs for the Public — Transmission". U.S. Centers for Disease Control and Prevention (CDC). Retrieved 2011-11-29.

[17]. Hughes RA (March 2000). "Drug injectors and the cleaning of needles and syringes". European Addiction Research 6 (1): 20–30.

[18]. Ibekwe RC, Ibeziako N. Hepatitis B vaccination status among health workers in Enugu, Nigeria. Niger J Clin Pract 2006; 9:7-10.

[19]. Jennifer A. Vaccinations in Pregnancy. Postgraduate Obstetrics & Gynaecology. Vol 31(7); 1-7.2011

[20]. Kerkar N (2005). "Hepatitis B in children: complexities in management". Pediatric transplantation 9 (5): 685–691.

[21]. Lai CL, Yuen MF (July 2007). "The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points". Annals of Internal Medicine 147 (1): 58–61.

[22]. LeFevre ML (May 27, 2014). "Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: U.S. Preventive Services Task Force Recommendation Statement". Annals of internal medicine 161 (1): 58–66.

[23]. Lutgens SP, Nelissen EC, van Loo IH, Koek GH, Derhaag JG, Dunselman GA (22 July 2009).

[24]. Olubuyide IO, Ola SO, Aliyu B, Dosumu OO, Arotiba JT, Olaleye O (1997). Prevalence and epidemiological characteristics of hepatitis B and C infections among doctors and dentists in Nigeria. East Afr.Med. J. 74:357-361.

[25]. Ogoina D, Pondei K, Adetunji B. Prevalence of hepatitis B vaccination among health care workers in Nigeria in 2011–12. Int J Occup Environ Med 2014;5:51-56.

[26]. Oliveri F, Brunetto MR, Actis GC, Bonino F (November 1991). "Pathobiology of chronic hepatitis virus infection and hepatocellular carcinoma (HCC)". Ital J Gastroenterol 23 (8): 498– 502.

[27]. Prüss-Ustün A, Rapiti E HY. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med 2005;48:482-90.

[28]. Raphael Rubin; David S. Strayer (2008). Rubin's Pathology: clinicopathologic foundations of medicine; [includes access to online text, cases, images, and audio review questions!] (5 ed.). Philadelphia [u.a.]:

[29]. Samuel S.O, Aderibigbe S.A, Salami T.A.T and O. A. Babatunde O.A. Health workers’ knowledge, attitude and behaviour towards hepatitis B infection in Southern Nigeria. Int. J. Med. Med. Sci. Vol. 1(10). pp. 418-424, October, 2009

[30]. S Schillie, T Murphy, M Sawyer, K Ly, E Hughes et.al. CDC Guidance For Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management. MMWR / December 20, 2013 / Vol. 62 / No. 10

[31]. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006). "Hepatitis B virus infection: epidemiology and vaccination.". Epidemiologic reviews 28: 112–25.

[32]. Taylor JM (2006). "Hepatitis delta virus". Virology 344 (1): 71–76.

[33]. "To do or not to do: IVF and ICSI in chronic hepatitis B virus carriers". Human Reproduction 24 (11): 2676–8.

[34]. US Public Health Service. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 2001; 29:50(No. RR-11).

[35]. WHO. The world health report: reducing risks, promoting healthy life. 2012.

[36]. Wolters Kluwer/Lippincott Williams & Wilkins. p. 638.

[37]. Wong, F; Pai, R; Van Schalkwyk, J; Yoshida, EM (2014). "Hepatitis B in pregnancy: a concise review of neonatal vertical transmission and antiviral prophylaxis.” Annals of hepatology 13 (2): 187–95.